Takeda to Launch Ads Touting Safety of Actos (Japan)
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical Co. has launched print ads touting the safety of its diabetes drug Actos (pioglitazone hydrochloride), a campaign that began just days after the U.S. FDA put new safety warnings on rival drug Avandia (rosiglitazone maleate), from GlaxoSmithKline PLC. The full page ads, running in approximately 60 newspapers and several magazines in the U.S., tell patients: "If you have type 2 diabetes, Actos has been shown to lower blood sugar without increasing your risk of having a heart attack or stroke." Takeda received a marketing age after the FDA's decision compelling Glaxo to add a new warning to Avandia's prescribing label about potential heart-attack risks for patients taking the drug. The FDA will also ask makers of other diabetes drugs, including Takeda, to note in their labels that their drugs haven't been proven to reduce cardiovascular risk. Shay Weisbrich, general manager of diabetes marketing at Takeda, said the company is concerned that the Avandia controversy has scared some patients off oral diabetes drugs altogether. "The more media there is out there, the more confusing it is for patients. We designed [the ads] to cut through that and provide some clarity," she said. Some doctors have been switching their patients to Actos from Avandia in recent months, as concerns about Avandia's safety have increased. (Click here for more - May Require Paid Subscription
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.